A 78-year-old male with a history of CHF and atrial fibrillation complains of nausea, vomiting, and seeing 'yellow halos' around lights. His medications include digoxin, furosemide, and lisinopril. Vital signs: BP 98/60, P 40/min, R 18. The monitor shows a 3rd-degree AV block. His serum potassium is 6.2 mEq/L.
Which intervention is most appropriate for managing this patient's hyperkalemia and bradycardia in the prehospital setting?
- Transcutaneous pacing at 70 bpm.
- Administering Digoxin Immune Fab (DigiFab).
- Atropine 1 mg IV, repeated up to 3 mg.
- Calcium chloride 1g and sodium bicarbonate 50 mEq IV. (correct answer)
Explanation: When you encounter a patient with suspected digoxin toxicity presenting with severe hyperkalemia and bradycardia, your priority is addressing the life-threatening electrolyte imbalance and cardiac rhythm. This patient shows classic digoxin toxicity signs: visual disturbances (yellow halos), nausea/vomiting, and cardiac conduction abnormalities. The combination of severe hyperkalemia (6.2 mEq/L) and 3rd-degree AV block creates immediate cardiac risk. Calcium chloride stabilizes cardiac cell membranes, protecting against hyperkalemia-induced arrhythmias, while sodium bicarbonate helps shift potassium intracellularly, lowering serum levels. This dual approach addresses both the membrane instability and begins correcting the electrolyte imbalance. Answer A (transcutaneous pacing) treats the bradycardia symptomatically but ignores the underlying hyperkalemia, which could trigger fatal arrhythmias during pacing attempts. Answer B (DigiFab) is the definitive treatment for digoxin toxicity but isn't typically available in prehospital settings and doesn't immediately address the hyperkalemia crisis. Answer C (atropine) is ineffective for 3rd-degree AV blocks, as the problem lies below the AV node where atropine has minimal effect, and it doesn't address the dangerous potassium level. Remember this pattern: when you see hyperkalemia above 6.0 mEq/L with cardiac rhythm disturbances, calcium is your first-line membrane stabilizer, followed by agents that shift potassium intracellularly. Always treat the underlying electrolyte emergency before attempting rhythm interventions that could destabilize an already compromised cardiac system.